[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Glucagon Like Peptide 2 Receptor Market Report 2018

January 2018 | 96 pages | ID: UA4A046D5A6QEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Glucagon Like Peptide 2 Receptor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Glucagon Like Peptide 2 Receptor in these regions, from 2012 to 2022 (forecast).
United States Glucagon Like Peptide 2 Receptor market competition by top manufacturers/players, with Glucagon Like Peptide 2 Receptor sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Hanmi Pharmaceuticals Co Ltd
  • Naia Ltd
  • Shire Plc
  • Tasly Pharmaceutical Group Co Ltd
  • Zealand Pharma AS
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • FE-203799
  • Glepaglutide
  • GXG-8
  • HM-15910
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Short Bowel Syndrome
  • Diabetes
  • Diarrhea
  • Obesity
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Glucagon Like Peptide 2 Receptor Market Report 2017

1 GLUCAGON LIKE PEPTIDE 2 RECEPTOR OVERVIEW

1.1 Product Overview and Scope of Glucagon Like Peptide 2 Receptor
1.2 Classification of Glucagon Like Peptide 2 Receptor by Product Category
  1.2.1 United States Glucagon Like Peptide 2 Receptor Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Glucagon Like Peptide 2 Receptor Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 FE-203799
  1.2.4 Glepaglutide
  1.2.5 GXG-8
  1.2.6 HM-15910
  1.2.7 Others
1.3 United States Glucagon Like Peptide 2 Receptor Market by Application/End Users
  1.3.1 United States Glucagon Like Peptide 2 Receptor Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Short Bowel Syndrome
  1.3.3 Diabetes
  1.3.4 Diarrhea
  1.3.5 Obesity
  1.3.6 Others
1.4 United States Glucagon Like Peptide 2 Receptor Market by Region
  1.4.1 United States Glucagon Like Peptide 2 Receptor Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Glucagon Like Peptide 2 Receptor Status and Prospect (2012-2022)
  1.4.3 Southwest Glucagon Like Peptide 2 Receptor Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Glucagon Like Peptide 2 Receptor Status and Prospect (2012-2022)
  1.4.5 New England Glucagon Like Peptide 2 Receptor Status and Prospect (2012-2022)
  1.4.6 The South Glucagon Like Peptide 2 Receptor Status and Prospect (2012-2022)
  1.4.7 The Midwest Glucagon Like Peptide 2 Receptor Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Glucagon Like Peptide 2 Receptor (2012-2022)
  1.5.1 United States Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2012-2022)
  1.5.2 United States Glucagon Like Peptide 2 Receptor Revenue and Growth Rate (2012-2022)

2 UNITED STATES GLUCAGON LIKE PEPTIDE 2 RECEPTOR MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Glucagon Like Peptide 2 Receptor Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Glucagon Like Peptide 2 Receptor Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Glucagon Like Peptide 2 Receptor Average Price by Players/Suppliers (2012-2017)
2.4 United States Glucagon Like Peptide 2 Receptor Market Competitive Situation and Trends
  2.4.1 United States Glucagon Like Peptide 2 Receptor Market Concentration Rate
  2.4.2 United States Glucagon Like Peptide 2 Receptor Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Glucagon Like Peptide 2 Receptor Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES GLUCAGON LIKE PEPTIDE 2 RECEPTOR SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Glucagon Like Peptide 2 Receptor Sales and Market Share by Region (2012-2017)
3.2 United States Glucagon Like Peptide 2 Receptor Revenue and Market Share by Region (2012-2017)
3.3 United States Glucagon Like Peptide 2 Receptor Price by Region (2012-2017)

4 UNITED STATES GLUCAGON LIKE PEPTIDE 2 RECEPTOR SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Glucagon Like Peptide 2 Receptor Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Glucagon Like Peptide 2 Receptor Revenue and Market Share by Type (2012-2017)
4.3 United States Glucagon Like Peptide 2 Receptor Price by Type (2012-2017)
4.4 United States Glucagon Like Peptide 2 Receptor Sales Growth Rate by Type (2012-2017)

5 UNITED STATES GLUCAGON LIKE PEPTIDE 2 RECEPTOR SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Glucagon Like Peptide 2 Receptor Sales and Market Share by Application (2012-2017)
5.2 United States Glucagon Like Peptide 2 Receptor Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES GLUCAGON LIKE PEPTIDE 2 RECEPTOR PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Hanmi Pharmaceuticals Co Ltd
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Glucagon Like Peptide 2 Receptor Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Naia Ltd
  6.2.2 Glucagon Like Peptide 2 Receptor Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Naia Ltd Glucagon Like Peptide 2 Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Shire Plc
  6.3.2 Glucagon Like Peptide 2 Receptor Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Shire Plc Glucagon Like Peptide 2 Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Tasly Pharmaceutical Group Co Ltd
  6.4.2 Glucagon Like Peptide 2 Receptor Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Zealand Pharma AS
  6.5.2 Glucagon Like Peptide 2 Receptor Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Zealand Pharma AS Glucagon Like Peptide 2 Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview

7 GLUCAGON LIKE PEPTIDE 2 RECEPTOR MANUFACTURING COST ANALYSIS

7.1 Glucagon Like Peptide 2 Receptor Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Glucagon Like Peptide 2 Receptor

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Glucagon Like Peptide 2 Receptor Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Glucagon Like Peptide 2 Receptor Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES GLUCAGON LIKE PEPTIDE 2 RECEPTOR MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Glucagon Like Peptide 2 Receptor Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Glucagon Like Peptide 2 Receptor Sales Volume Forecast by Type (2017-2022)
11.3 United States Glucagon Like Peptide 2 Receptor Sales Volume Forecast by Application (2017-2022)
11.4 United States Glucagon Like Peptide 2 Receptor Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Glucagon Like Peptide 2 Receptor
Figure United States Glucagon Like Peptide 2 Receptor Market Size (K Pcs) by Type (2012-2022)
Figure United States Glucagon Like Peptide 2 Receptor Sales Volume Market Share by Type (Product Category) in 2016
Figure FE-203799 Product Picture
Figure Glepaglutide Product Picture
Figure GXG-8 Product Picture
Figure HM-15910 Product Picture
Figure Others Product Picture
Figure United States Glucagon Like Peptide 2 Receptor Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Glucagon Like Peptide 2 Receptor by Application in 2016
Figure Short Bowel Syndrome Examples
Table Key Downstream Customer in Short Bowel Syndrome
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Diarrhea Examples
Table Key Downstream Customer in Diarrhea
Figure Obesity Examples
Table Key Downstream Customer in Obesity
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Glucagon Like Peptide 2 Receptor Market Size (Million USD) by Region (2012-2022)
Figure The West Glucagon Like Peptide 2 Receptor Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Glucagon Like Peptide 2 Receptor Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Glucagon Like Peptide 2 Receptor Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Glucagon Like Peptide 2 Receptor Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Glucagon Like Peptide 2 Receptor Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Glucagon Like Peptide 2 Receptor Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Glucagon Like Peptide 2 Receptor Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Glucagon Like Peptide 2 Receptor Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Glucagon Like Peptide 2 Receptor Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Glucagon Like Peptide 2 Receptor Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Glucagon Like Peptide 2 Receptor Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Glucagon Like Peptide 2 Receptor Sales Share by Players/Suppliers
Figure 2017 United States Glucagon Like Peptide 2 Receptor Sales Share by Players/Suppliers
Figure United States Glucagon Like Peptide 2 Receptor Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Glucagon Like Peptide 2 Receptor Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Glucagon Like Peptide 2 Receptor Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Glucagon Like Peptide 2 Receptor Revenue Share by Players/Suppliers
Figure 2017 United States Glucagon Like Peptide 2 Receptor Revenue Share by Players/Suppliers
Table United States Market Glucagon Like Peptide 2 Receptor Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Glucagon Like Peptide 2 Receptor Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Glucagon Like Peptide 2 Receptor Market Share of Top 3 Players/Suppliers
Figure United States Glucagon Like Peptide 2 Receptor Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Glucagon Like Peptide 2 Receptor Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Glucagon Like Peptide 2 Receptor Product Category
Table United States Glucagon Like Peptide 2 Receptor Sales (K Pcs) by Region (2012-2017)
Table United States Glucagon Like Peptide 2 Receptor Sales Share by Region (2012-2017)
Figure United States Glucagon Like Peptide 2 Receptor Sales Share by Region (2012-2017)
Figure United States Glucagon Like Peptide 2 Receptor Sales Market Share by Region in 2016
Table United States Glucagon Like Peptide 2 Receptor Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Glucagon Like Peptide 2 Receptor Revenue Share by Region (2012-2017)
Figure United States Glucagon Like Peptide 2 Receptor Revenue Market Share by Region (2012-2017)
Figure United States Glucagon Like Peptide 2 Receptor Revenue Market Share by Region in 2016
Table United States Glucagon Like Peptide 2 Receptor Price (USD/Pcs) by Region (2012-2017)
Table United States Glucagon Like Peptide 2 Receptor Sales (K Pcs) by Type (2012-2017)
Table United States Glucagon Like Peptide 2 Receptor Sales Share by Type (2012-2017)
Figure United States Glucagon Like Peptide 2 Receptor Sales Share by Type (2012-2017)
Figure United States Glucagon Like Peptide 2 Receptor Sales Market Share by Type in 2016
Table United States Glucagon Like Peptide 2 Receptor Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Glucagon Like Peptide 2 Receptor Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Glucagon Like Peptide 2 Receptor by Type (2012-2017)
Figure Revenue Market Share of Glucagon Like Peptide 2 Receptor by Type in 2016
Table United States Glucagon Like Peptide 2 Receptor Price (USD/Pcs) by Types (2012-2017)
Figure United States Glucagon Like Peptide 2 Receptor Sales Growth Rate by Type (2012-2017)
Table United States Glucagon Like Peptide 2 Receptor Sales (K Pcs) by Application (2012-2017)
Table United States Glucagon Like Peptide 2 Receptor Sales Market Share by Application (2012-2017)
Figure United States Glucagon Like Peptide 2 Receptor Sales Market Share by Application (2012-2017)
Figure United States Glucagon Like Peptide 2 Receptor Sales Market Share by Application in 2016
Table United States Glucagon Like Peptide 2 Receptor Sales Growth Rate by Application (2012-2017)
Figure United States Glucagon Like Peptide 2 Receptor Sales Growth Rate by Application (2012-2017)
Table Hanmi Pharmaceuticals Co Ltd Basic Information List
Table Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Sales Growth Rate (2012-2017)
Figure Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Sales Market Share in United States (2012-2017)
Figure Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Revenue Market Share in United States (2012-2017)
Table Naia Ltd Basic Information List
Table Naia Ltd Glucagon Like Peptide 2 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Naia Ltd Glucagon Like Peptide 2 Receptor Sales Growth Rate (2012-2017)
Figure Naia Ltd Glucagon Like Peptide 2 Receptor Sales Market Share in United States (2012-2017)
Figure Naia Ltd Glucagon Like Peptide 2 Receptor Revenue Market Share in United States (2012-2017)
Table Shire Plc Basic Information List
Table Shire Plc Glucagon Like Peptide 2 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Shire Plc Glucagon Like Peptide 2 Receptor Sales Growth Rate (2012-2017)
Figure Shire Plc Glucagon Like Peptide 2 Receptor Sales Market Share in United States (2012-2017)
Figure Shire Plc Glucagon Like Peptide 2 Receptor Revenue Market Share in United States (2012-2017)
Table Tasly Pharmaceutical Group Co Ltd Basic Information List
Table Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Sales Growth Rate (2012-2017)
Figure Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Sales Market Share in United States (2012-2017)
Figure Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Revenue Market Share in United States (2012-2017)
Table Zealand Pharma AS Basic Information List
Table Zealand Pharma AS Glucagon Like Peptide 2 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Zealand Pharma AS Glucagon Like Peptide 2 Receptor Sales Growth Rate (2012-2017)
Figure Zealand Pharma AS Glucagon Like Peptide 2 Receptor Sales Market Share in United States (2012-2017)
Figure Zealand Pharma AS Glucagon Like Peptide 2 Receptor Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Glucagon Like Peptide 2 Receptor
Figure Manufacturing Process Analysis of Glucagon Like Peptide 2 Receptor
Figure Glucagon Like Peptide 2 Receptor Industrial Chain Analysis
Table Raw Materials Sources of Glucagon Like Peptide 2 Receptor Major Players/Suppliers in 2016
Table Major Buyers of Glucagon Like Peptide 2 Receptor
Table Distributors/Traders List
Figure United States Glucagon Like Peptide 2 Receptor Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Glucagon Like Peptide 2 Receptor Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Glucagon Like Peptide 2 Receptor Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Glucagon Like Peptide 2 Receptor Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Glucagon Like Peptide 2 Receptor Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Glucagon Like Peptide 2 Receptor Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Glucagon Like Peptide 2 Receptor Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Glucagon Like Peptide 2 Receptor Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Glucagon Like Peptide 2 Receptor Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Glucagon Like Peptide 2 Receptor Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Glucagon Like Peptide 2 Receptor Sales Volume Share Forecast by Region (2017-2022)
Figure United States Glucagon Like Peptide 2 Receptor Sales Volume Share Forecast by Region (2017-2022)
Figure United States Glucagon Like Peptide 2 Receptor Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications